HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tom Sprong Selected Research

VU 0405652

12/2005Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tom Sprong Research Topics

Disease

11Q Fever (Fever, Q)
01/2017 - 05/2012
7Meningococcal Infections
02/2012 - 10/2004
6Sepsis (Septicemia)
02/2012 - 11/2003
4Infections
04/2022 - 06/2006
4Inflammation (Inflammations)
07/2011 - 11/2003
4Septic Shock (Toxic Shock Syndrome)
11/2009 - 06/2004
4Shock
10/2009 - 12/2005
2Endocarditis
06/2014 - 09/2013
2Endotoxemia
05/2007 - 04/2006
1Staphylococcal Infections
12/2019
1Fatigue
01/2017
1Dementia (Dementias)
01/2016
1Pneumococcal Infections
08/2014
1Rheumatoid Arthritis
06/2014
1Infected Aneurysm
09/2013
1Hereditary Complement Deficiency Diseases
04/2012
1Arthritis (Polyarthritis)
12/2011
1Experimental Arthritis
12/2011
1Atrial Fibrillation
07/2011
1Disseminated Intravascular Coagulation
11/2009
1Parasitemia
07/2007
1Complement Factor D Deficiency
06/2006
1Crohn Disease (Crohn's Disease)
07/2004

Drug/Important Bio-Agent (IBA)

9CytokinesIBA
01/2016 - 04/2004
5Complement System Proteins (Complement)IBA
11/2009 - 11/2003
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2014 - 04/2006
4Interleukin-10 (Interleukin 10)IBA
10/2009 - 07/2004
3Complement Membrane Attack Complex (Membrane Attack Complex)IBA
04/2012 - 07/2007
3Interleukin-12 (IL 12)IBA
10/2009 - 04/2006
3LipopolysaccharidesIBA
10/2009 - 04/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2007 - 12/2005
2Penicillins (Penicillin)FDA Link
12/2019 - 08/2014
2Anti-Bacterial Agents (Antibiotics)IBA
01/2016 - 08/2014
2Toll-Like Receptors (Toll-Like Receptor)IBA
09/2015 - 07/2004
2Proteins (Proteins, Gene)FDA Link
09/2015 - 07/2007
2C-Reactive ProteinIBA
01/2015 - 01/2009
2Immunoglobulin G (IgG)IBA
06/2014 - 05/2012
2EnzymesIBA
01/2014 - 05/2007
2Macrophage Migration-Inhibitory FactorsIBA
02/2012 - 05/2007
2LectinsIBA
11/2009 - 10/2004
2Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
11/2009 - 10/2004
2Interleukin-1beta (Interleukin 1 beta)IBA
10/2009 - 12/2005
2InterleukinsIBA
05/2007 - 04/2006
1MacrolidesIBA
04/2022
1Ethambutol (Myambutol)FDA LinkGeneric
04/2022
1Floxacillin (Flucloxacillin)IBA
12/2019
1Doxycycline (Periostat)FDA LinkGeneric
01/2017
1Interleukin-22 (IL-22)IBA
01/2017
1IntegrinsIBA
09/2015
1Pattern Recognition ReceptorsIBA
09/2015
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
09/2015
1NucleotidesIBA
09/2015
1Rituximab (Mabthera)FDA Link
06/2014
1Interferon-gamma (Interferon, gamma)IBA
01/2014
1VaccinesIBA
12/2013
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
09/2013
1InterferonsIBA
06/2013
1CholesterolIBA
07/2011
1ThrombinFDA Link
07/2011
1Dacarbazine (DIC)FDA LinkGeneric
11/2009
1PTX3 proteinIBA
01/2009
1Indicators and Reagents (Reagents)IBA
01/2009
1ImmunosorbentsIBA
05/2007
1Complement Factor D (Factor D)IBA
06/2006
1ElementsIBA
06/2006
1A-factor (Streptomyces)IBA
06/2006
1AlbuminsIBA
04/2006
1Interleukin-6 (Interleukin 6)IBA
04/2006
1Interleukin-8 (Interleukin 8)IBA
04/2006
1VU 0405652IBA
12/2005
1LigandsIBA
07/2004
1Peptidoglycan (Murein)IBA
07/2004
1Lipoproteins (Lipoprotein)IBA
04/2004

Therapy/Procedure

3Therapeutics
12/2019 - 07/2011
1Immunotherapy
06/2014
1Cell- and Tissue-Based Therapy (Cell Therapy)
06/2014
1Blood Vessel Prosthesis
09/2013